LncRNA GAS5 regulates the Wnt/β-catenin pathway through the miR-18a-5p/AXIN2/GSK3β axis to inhibit the proliferation and migration of bladder cancer cells

LncRNA PTENP1 inhibits cervical cancer progression by suppressing miR-106b

(2020) Yingrui Fan et al.   Artificial Cells Nanomedicine and Biotechnology

LncRNA growth arrest‐specific transcript 5 targets miR‐21 gene and regulates bladder cancer cell proliferation and apoptosis through PTEN

(2020) Dong Chen et al.   Cancer Medicine

The lncRNA-GAS5/miR-221-3p/DKK2 Axis Modulates ABCB1-Mediated Adriamycin Resistance of Breast Cancer via the Wnt/β-Catenin Signaling Pathway

(2020) Zhaolin Chen et al.   Molecular Therapy-Nucleic Acids

LncRNA BCRT1 promotes breast cancer progression by targeting miR-1303/PTBP3 axis

(2020) Yiran Liang et al.   Molecular Cancer

Long non-coding RNA CASC9 promotes tumor growth and metastasis via modulating FZD6/Wnt/β-catenin signaling pathway in bladder cancer

(2020) Yonghao Zhan et al.   JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH

The Non-Coding RNA GAS5 and Its Role in Tumor Therapy-Induced Resistance

(2020) George I. Lambrou et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Beyond the RNA-dependent function of LncRNA genes

(2020) Tamer Ali et al.   eLife

Explore prognostic biomarker of bladder cancer based on competing endogenous network

(2020) Faping Li et al.   BIOSCIENCE REPORTS

The long non-coding RNA LUCAT1 is a negative feedback regulator of interferon responses in humans

(2020) Shiuli Agarwal et al.   Nature Communications

miR-4721, Induced by EBV-miR-BART22, Targets GSK3β to Enhance the Tumorigenic Capacity of NPC through the WNT/β-catenin Pathway

(2020) ZiBo Tang et al.   Molecular Therapy-Nucleic Acids

Present Status, Limitations and Future Directions of Treatment Strategies Using Fucoidan-Based Therapies in Bladder Cancer

(2020) Yasuyoshi Miyata et al.   Cancers

Emerging roles of long noncoding RNAs in chemoresistance of pancreatic cancer

(2020) Wangkai Xie et al.   SEMINARS IN CANCER BIOLOGY

CDX2 inhibits the proliferation and tumor formation of colon cancer cells by suppressing Wnt/β-catenin signaling via transactivation of GSK-3β and Axin2 expression

(2019) Junhui Yu et al.   Cell Death & Disease

Collagen-rich airway smooth muscle cells are a metastatic niche for tumor colonization in the lung

(2019) Yu-Cheng Lee et al.   Nature Communications

Gene Expression Analyses in Non Muscle Invasive Bladder Cancer Reveals a Role for Alternative Splicing and Tp53 Status

(2019) Marta Dueñas et al.   Scientific Reports

Systematic chemical screening identifies disulfiram as a repurposed drug that enhances sensitivity to cisplatin in bladder cancer: a summary of preclinical studies

(2019) Yuki Kita et al.   BRITISH JOURNAL OF CANCER

DAX1 promotes cervical cancer cell growth and tumorigenicity through activation of Wnt/β-catenin pathway via GSK3β

(2018) Xiao-Fang Liu et al.   Cell Death & Disease

Long noncoding RNA GAS5 promotes bladder cancer cells apoptosis through inhibiting EZH2 transcription

(2018) Miao Wang et al.   Cell Death & Disease

Prognostic value of association of OCT4 with LEF1 expression in esophageal squamous cell carcinoma and their impact on epithelial-mesenchymal transition, invasion, and migration

(2018) Yue Zhao et al.   Cancer Medicine

Lowly-expressed lncRNA GAS5 facilitates progression of ovarian cancer through targeting miR-196-5p and thereby regulating HOXA5

(2018) Hongmin Zhao et al.   GYNECOLOGIC ONCOLOGY

LncRNA GAS6-AS2 promotes bladder cancer proliferation and metastasis via GAS6-AS2/miR-298/CDK9 axis

(2018) Xin Rui et al.   JOURNAL OF CELLULAR AND MOLECULAR MEDICINE

LncRNA miR143HG suppresses bladder cancer development through inactivating Wnt/β-catenin pathway by modulating miR-1275/AXIN2 axis

(2018) Hui Xie et al.   JOURNAL OF CELLULAR PHYSIOLOGY

LncRNA-mediated regulation of cell signaling in cancer

(2017) W-X Peng et al.   ONCOGENE

Downregulation of GAS5 Promotes Bladder Cancer Cell Proliferation, Partly by Regulating CDK6

(2013) Zhihong Liu et al.   PLoS One

Cancer treatment and survivorship statistics, 2012

(2012) Rebecca Siegel et al.   CA-A CANCER JOURNAL FOR CLINICIANS